Horizon Discovery

For almost 15 years Millennium Science has partnered with Dharmacon to bring customers throughout Australia and New Zealand the very best gene modulation tools in the market. Dharmacon's expertise in bioinformatics, RNA biology, and synthesis chemistry has allowed the company to develop a complete line of products for the RNAi researcher.

horizon-discovery-logo.pngIn 2017, Horizon Discovery, a translational genomics company developing and supplying patient-relevant drug discovery tools and diagnostic reference material, acquired Dharmacon to strengthen its cell biology portfolio, which applies gene-editing and gene-modulation platforms to design, engineer, and apply cells for new treatments. Horizon Discovery has sites in the UK and in the US.

Now in 2019, Horizon Discovery has partnered with Millennium Science in Australia and New Zealand to offer almost the entirety of their portfolio which includes cell lines, live animal models, and bioproduction cell lines, in addition to the Dharmacon portfolio of gene modulation research tools.  Horizon Discovery’s reference standard portfolio remains with MetaGene in Australia.

We are pleased to add the Horizon Discovery portfolio to the range of leading-edge cell biology and genomics technology platforms we offer.

To learn more, please speak with your local Millennium Science Territory Manager, or to arrange a seminar or to order Horizon Discovery products, please contact us at sales@mscience.com.au or sales@mscience.co.nz.

Enquiry Form

Required fields are marked with*